In the latest trading session, 0.75 million Adial Pharmaceuticals Inc (NASDAQ:ADIL) shares changed hands as the company’s beta touched 1.22. With the company’s most recent per share price at $1.04 changed hands at -$0.03 or -2.75% at last look, the market valuation stands at $6.66M. ADIL’s current price is a discount, trading about -300.96% off its 52-week high of $4.17. The share price had its 52-week low at $0.76, which suggests the last value was 26.92% up since then. When we look at Adial Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.13 million shares, with the 3-month average coming to 145.50K.
Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information
Instantly ADIL was in red as seen in intraday trades today. With action 3.03%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -44.05%, with the 5-day performance at 3.03% in the green. However, in the 30-day time frame, Adial Pharmaceuticals Inc (NASDAQ:ADIL) is 3.03% up. Looking at the short shares, we see there were 78882.0 shares sold at short interest cover period of 0.65 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adial Pharmaceuticals Inc (ADIL) estimates and forecasts
Data shows that the Adial Pharmaceuticals Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -23.49% over the past 6 months, a 38.09% in annual growth rate that is considerably higher than the industry average of 17.60%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 38.36%. The 2024 estimates are for Adial Pharmaceuticals Inc earnings to increase by 27.22%.
ADIL Dividends
Adial Pharmaceuticals Inc is expected to release its next quarterly earnings report in January.
Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.80% of Adial Pharmaceuticals Inc shares while 3.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.08%.
Among Mutual Funds, the top two as of Sep 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 35.93 shares estimated at $37366.0 under it, the former controlled 0.56% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.15% of the shares, roughly 9.36 shares worth around $9734.0.
